YungShin Global Holding Corp Market Cap ($497.64 Million)
Market Cap & Net Worth: YungShin Global Holding Corp (3705)
YungShin Global Holding Corp market cap. YungShin Global Holding Corp (TW:3705) has a market capitalization of $497.64 Million (NT$15.80 Billion) as of November 4, 2026. Listed on the TW stock exchange, this Taiwan-based company holds position #11883 globally and #433 in its home market, demonstrating a 0.34% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying YungShin Global Holding Corp's stock price NT$59.30 by its total outstanding shares 266365000 (266.37 Million). Also see YungShin Global Holding Corp (3705) cash flow conversion for how efficiently the company converts equity into cash flow.
YungShin Global Holding Corp Market Cap History (2015–2026)
YungShin Global Holding Corp market cap history from 2015 to 2026. Data shows growth from $259.57 Million to $497.64 Million (6.30% CAGR). Check current stock price of YungShin Global Holding Corp for real-time trading data and today's change.
YungShin Global Holding Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how YungShin Global Holding Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 3705 shareholders equity momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.06x
YungShin Global Holding Corp's market cap is 0.06 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.54x
YungShin Global Holding Corp's market cap is 0.54 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $258.86 Million | $6.19 Billion | $657.99 Million | 0.04x | 0.39x |
| 2017 | $234.42 Million | $6.62 Billion | $514.06 Million | 0.04x | 0.46x |
| 2018 | $241.83 Million | $7.51 Billion | $701.98 Million | 0.03x | 0.34x |
| 2019 | $277.12 Million | $8.19 Billion | $748.60 Million | 0.03x | 0.37x |
| 2020 | $302.23 Million | $8.08 Billion | $791.72 Million | 0.04x | 0.38x |
| 2021 | $304.14 Million | $7.81 Billion | $736.62 Million | 0.04x | 0.41x |
| 2022 | $386.03 Million | $7.31 Billion | $839.03 Million | 0.05x | 0.46x |
| 2023 | $390.23 Million | $7.03 Billion | $827.30 Million | 0.06x | 0.47x |
| 2024 | $452.33 Million | $8.03 Billion | $1.17 Billion | 0.06x | 0.39x |
| 2025 | $478.34 Million | $8.38 Billion | $880.82 Million | 0.06x | 0.54x |
Competitor Companies of 3705 by Market Capitalization
Companies near YungShin Global Holding Corp in the global market cap rankings as of November 4, 2026. Also see YungShin Global Holding Corp (3705) total assets for a full breakdown of the balance sheet.
Key companies related to YungShin Global Holding Corp by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #509 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #534 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #580 globally with a market cap of $46.03 Billion USD ( CN¥314.55 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #509 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #534 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.90 |
| #580 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $46.03 Billion | CN¥49.31 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of YungShin Global Holding Corp (2015–2026)
Market capitalization of YungShin Global Holding Corp from 2015 to today. Between 2015 and today, YungShin Global Holding Corp's market cap moved from $259.57 Million to $ 497.64 Million, with a yearly change of 6.30%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$497.64 Million | +4.04% |
| 2025 | NT$478.34 Million | +5.75% |
| 2024 | NT$452.33 Million | +15.91% |
| 2023 | NT$390.23 Million | +1.09% |
| 2022 | NT$386.03 Million | +26.92% |
| 2021 | NT$304.14 Million | +0.63% |
| 2020 | NT$302.23 Million | +9.06% |
| 2019 | NT$277.12 Million | +14.59% |
| 2018 | NT$241.83 Million | +3.16% |
| 2017 | NT$234.42 Million | -9.44% |
| 2016 | NT$258.86 Million | -0.27% |
| 2015 | NT$259.57 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of YungShin Global Holding Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $497.64 Million USD |
| MoneyControl | $497.64 Million USD |
| MarketWatch | $497.64 Million USD |
| marketcap.company | $497.64 Million USD |
| Reuters | $497.64 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About YungShin Global Holding Corp
YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, M… Read more